We are looking for an experienced Project Manager/Researcher to join our team for the EC-funded program ‘VACCELERATE’
The Center for Clinical Epidemiology and Outcomes Research - CLEO (https://www.cleoresearch.org) was given the Gold award in the category for Patient Safety for the National Program for the Prevention and Control of Hospital Acquired Infections and Antimicrobial Resistance, "Greek Infection Prevention Program, GRIPP-SNF", at the Patient Partnerships Awards 2022 (https://www.patientawards.gr/) organized by Health Daily of BOUSSIAS Communications.
Written by Dimitra Kousi, Junior Biostatistician, CLEO.
What is the microbiome?
Trillions of microorganisms colonize our gastrointestinal tract, skin, genito-urinary system etc., together forming the ‘human microbiome’. Most of these microorganisms are bacteria, but the microbiome also includes fungi, protozoa and viruses. Some of these microorganisms have a beneficial effect on our health, others have been associated with harmful functions while others remain neutral.
Recent studies on the human microbiome showed that 56% of the total cell count in our body are not human cells, but bacterial, weighing nearly 0,2 kg (almost as much as a zucchini!) (1). The microbiome is unique for each and every one of us and, in a way, constitutes our identity (2). The vast majority of the human microbial communities inhabit the gastrointestinal tract, and this is the reason why the gut microbiome (GM) has attracted the most attention.
Center for Clinical Epidemiology and Outcomes Research (CLEO) was founded thanks to a grant from the Stavros Niarchos Foundation, which from 2011 until today continues to support its operation as a major donor.
